The top 5 studies from June 2019
Ranging from biomarkers that can define PTB risk to the impact of age and fertility, these are five of the most noteworthy studies published in June 2019.
.jpeg?w=1500&fit=max&auto=format)
Benzodiazepines and spontaneous abortion
A new study from JAMA Psychiatry examines if all benzodiazepines, regardless of drug or duration of action, carry the same risk of spontaneous abortion.
Read more: Benzodiazepines and spontaneous abortion
©Cappi Thompson - stock.adobe.com
.jpeg?w=1500&fit=max&auto=format)
PTB
Results from a recent study published in Nature Medicine hold promise for development of biomarkers that could be used to define risk of PTB in African-American women.
Read more: Vaginal ‘signature’ for preterm birth in African-American women?
©Adele De Witte - stock.adobe.com
_1.jpeg?w=1500&fit=max&auto=format)
Test for Zika
For the first time, the US Food and Drug Administration (FDA) has authorized marketing of a test to detect Zika virus immunoglobulin (IgM) antibodies in the bloodstream.
Read more: FDA Authorizes Marketing Of First Zika Diagnostic
©Feng Yu -stock.adobe.com
.jpeg?w=1500&fit=max&auto=format)
Syncope and pregnancy
New research from The Journal of the American Heart Association illustrates why it's important for ob/gyns to discuss syncope history with their pregnant patients.
Read more: Frequency of and risks associated with syncope in pregnancy
©Photographee.eu - stock.adobe.com
.jpeg?w=1500&fit=max&auto=format)
Age and fertility
A new study published in the Journal of Women's Health indicates that millions of women may not realize the impact age has on fertility due to coverage of celebrity pregnancies in consumer magazines.
Read more: How women’s magazines misrepresent fertility in older women
©Farknot Architect - stock.adobe.com